Norges Bank’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-5,119,622
| Closed | -$84.5M | – | 404 |
|
|
2025
Q4 | $84.5M | Buy |
+5,119,622
| New | +$86.4M | 0.01% | 826 |
|
|
2025
Q3 | – | Sell |
-3,947,387
| Closed | -$55.2M | – | 452 |
|
|
2025
Q2 | $55.2M | Buy |
3,947,387
+899,781
| +30% | +$12.7M | 0.01% | 912 |
|
|
2025
Q1 | $41.4M | Buy |
3,047,606
+1,981,998
| +186% | +$38M | 0.01% | 1017 |
|
|
2024
Q4 | $21.7M | Buy |
1,065,608
+668,069
| +168% | +$17.1M | ﹤0.01% | 1217 |
|
|
2024
Q3 | $11.6M | Sell |
397,539
-426,402
| -52% | -$10.6M | ﹤0.01% | 1332 |
|
|
2024
Q2 | $19.1M | Sell |
823,941
-411,825
| -33% | -$7.91M | ﹤0.01% | 1227 |
|
|
2024
Q1 | $25.4M | Buy |
1,235,766
+83,120
| +7% | +$1.56M | ﹤0.01% | 1200 |
|
|
2023
Q4 | $24.7M | Buy |
1,152,646
+348,754
| +43% | +$6.91M | ﹤0.01% | 1207 |
|
|
2023
Q3 | $16.6M | Buy |
803,892
+223,558
| +39% | +$5.67M | ﹤0.01% | 1292 |
|
|
2023
Q2 | $17.1M | Sell |
580,334
-389,106
| -40% | -$10.9M | ﹤0.01% | 1320 |
|
|
2023
Q1 | $22.3M | Sell |
969,440
-54,766
| -5% | -$1.51M | ﹤0.01% | 1240 |
|
|
2022
Q4 | $28.5M | Buy |
1,024,206
+80,802
| +9% | +$2.4M | 0.01% | 1107 |
|
|
2022
Q3 | $29M | Buy |
943,404
+111,595
| +13% | +$3.63M | 0.01% | 1026 |
|
|
2022
Q2 | $24.5M | Sell |
831,809
-14,254
| -2% | -$373K | 0.01% | 1145 |
|
|
2022
Q1 | $27.2M | Sell |
846,063
-46
| -0% | -$1.58K | 0.01% | 1224 |
|
|
2021
Q4 | $37.7M | Sell |
846,109
-7,247
| -0.8% | -$343K | 0.01% | 1102 |
|
|
2021
Q3 | $43.1M | Buy |
853,356
+111,376
| +15% | +$6.28M | 0.01% | 998 |
|
|
2021
Q2 | $58.2M | Buy |
741,980
+144,214
| +24% | +$8.92M | 0.01% | 883 |
|
|
2021
Q1 | $34.1M | Sell |
597,766
-258,663
| -30% | -$17.3M | 0.01% | 1199 |
|
|
2020
Q4 | $71.7M | Sell |
856,429
-49,944
| -6% | -$3.02M | 0.02% | 750 |
|
|
2020
Q3 | $32.5M | Sell |
906,373
-26,206
| -3% | -$789K | 0.01% | 1107 |
|
|
2020
Q2 | $22.6M | Sell |
932,579
-15,959
| -2% | -$375K | 0.01% | 1358 |
|
|
2020
Q1 | $16.6M | Buy |
948,538
+325,000
| +52% | +$6.78M | 0.01% | 1371 |
|
|
2019
Q4 | $10.9M | Hold |
623,538
| – | – | ﹤0.01% | 1775 |
|
|
2019
Q3 | $9.55M | Buy |
623,538
+48,076
| +8% | +$918K | ﹤0.01% | 1791 |
|
|
2019
Q2 | $11.9M | Hold |
575,462
| – | – | ﹤0.01% | 1742 |
|
|
2019
Q1 | $13.4M | Buy |
+575,462
| New | +$12M | ﹤0.01% | 1695 |
|
|
2018
Q2 | – | Sell |
-265,616
| Closed | -$5.23M | – | 2139 |
|
|
2018
Q1 | $5.23M | Sell |
265,616
-384,384
| -59% | -$7.9M | ﹤0.01% | 1888 |
|
|
2017
Q4 | $10.2M | Buy |
+650,000
| New | +$11.7M | ﹤0.01% | 1735 |
|
Other funds holding DNLI
VCM
VPM
